Anita Garg plays a key role in establishing and managing the internal strategy and external commercial partnerships that support the mission and growth of the Population Council’s Center for Biomedical Research (CBR). This includes identifying and managing partnership opportunities, optimizing the commercial strategy for CBR’s products, working across functions to develop short- and long-term goals and milestones in alignment with CBR’s vision and resources, and supporting the team to secure new funding. In addition, Garg serves as a key adviser to and in support of the executive director on all strategic issues facing CBR.
During her 16+ year tenure at the International Partnership for Microbicides (IPM), Garg managed the team that developed and commercialized the monthly dapivirine vaginal ring (DVR), the first long-acting HIV prevention product for women. Garg also played a leading role in the acquisition and integration of IPM into the Council.
Prior to IPM, Garg spent five years as a biologist and research analyst developing vaccines for HIV and other pathogens at the NIH’s Vaccine Research Center.
Garg holds a master of science in biotechnology from Johns Hopkins University.